Citation only
via OpenAlex
Impact of Metformin on Healthspan-Related Outcomes and Incidence of Diseases of Aging in People with Type 2 Diabetes Mellitus: A Systematic Review
Amy Hai Yan Chan, Kebede Abera Beyene, Bertha Lai, Sarah Kim, Ivy Wu, Rana Al-Jawadi, Margaret Wu, Holly Foot, Gary Cheung, Xaviour J. Walker, Yoram Barak
Rejuvenation Research · 2026
Deregulated nutrient-sensing
Metformin
Systematic review
Randomized controlled trial
Meta-analysis
Review
Abstract
Metformin use may be associated with reduced risk of all-cause mortality as well as prevent the onset of diseases of aging, namely cardiovascular diseases (CVD), cancer, and dementia. We systematically reviewed recent studies to determine whether metformin can promote healthspan(definition) in people with type 2 diabetes mellitus (T2DM). A comprehensive literature search was conducted using Medline, Embase, and Scopus for randomized controlled trials (RCTs) and cohort studies evaluating the effect of metformin on the incidence of all-cause mortality. Publications investigating metformin's effects on CVD, cancer or dementia were included. Search was restricted to English-only publications between 2016 and 2021. Full-text review, data extraction, and assessment of risk of bias using the Newcastle-Ottawa Scale were undertaken. Of 130 articles reviewed, 27 met the inclusion criteria. All 27 studies are observational cohorts, and no RCTs met the inclusion criteria, so causality cannot be inferred. No RCTs met the inclusion criteria. Five studies investigated the effects of metformin on all-cause mortality, 17 on the incidence of cancer, 3 on CVD, and 4 on dementia. Data heterogeneity precluded meta-analysis. Included studies were of high quality with NOS scores of 6-9. Metformin use in individuals with T2DM was associated with reduced risk of all-cause mortality, incidence of CVDs, and dementia. Metformin was associated with a reduced risk of prostate cancer but otherwise effects varied with cancer type and remain inconclusive.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1177/15491684261462413
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Chan, A.H.Y., Beyene, K.A., Lai, B., Kim, S., Wu, I., Al-Jawadi, R., Wu, M., Foot, H., Cheung, G., Walker, X.J., & Barak, Y. (2026). Impact of Metformin on Healthspan-Related Outcomes and Incidence of Diseases of Aging in People with Type 2 Diabetes Mellitus: A Systematic Review. <em>Rejuvenation Research</em>. https://doi.org/10.1177/15491684261462413
Vancouver
Chan AHY, Beyene KA, Lai B, Kim S, Wu I, Al-Jawadi R, et al. Impact of Metformin on Healthspan-Related Outcomes and Incidence of Diseases of Aging in People with Type 2 Diabetes Mellitus: A Systematic Review. Rejuvenation Research. 2026. doi:10.1177/15491684261462413.
BibTeX
@article{amy2026Impact,
title = {Impact of Metformin on Healthspan-Related Outcomes and Incidence of Diseases of Aging in People with Type 2 Diabetes Mellitus: A Systematic Review},
author = {Amy Hai Yan Chan and Kebede Abera Beyene and Bertha Lai and Sarah Kim and Ivy Wu and Rana Al-Jawadi and Margaret Wu and Holly Foot and Gary Cheung and Xaviour J. Walker and Yoram Barak},
journal = {Rejuvenation Research},
year = {2026},
doi = {10.1177/15491684261462413},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Rejuvenation research 2026
Citation only
Impact of Metformin on Healthspan-Related Outcomes and Incidence of Diseases of Aging in People with Type 2 Diabetes Mellitus: A Systematic Review.
Journal of Clinical Medicine 2023
Open access · CC-BY
Effects of Intermittent Fasting on Regulation of Metabolic Homeostasis: A Systematic Review and Meta-Analysis in Health and Metabolic-Related Disorders
Neonatology 2017
Citation only
The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants
Frontiers in Medicine 2019
Open access · CC-BY
Frailty as a Predictor of Cognitive Disorders: A Systematic Review and Meta-Analysis
PLoS ONE 2025
Open access · CC-BY
The influence of type 2 diabetes and its metabolic correlates in middle-aged adults on cognition at mid and later life; A systematic review and meta-analysis
PLoS ONE 2013
Open access · CC-BY